Related Experiment Videos
Membranous nephropathy in a bone marrow transplant recipient
C Hiesse1, E Goldschmidt, G Santelli
1Nephrology Department, University Paris-South, Hospital Paul Brousse, Villejuif, France.
Summary
Nephrotic syndrome developed in a bone marrow transplant patient with chronic graft-versus-host disease (GVHD) after stopping cyclosporine (CsA). Renal biopsy confirmed membranous glomerulonephritis (MG), suggesting an autoimmune link.
Area of Science:
- Nephrology
- Immunology
- Hematology
Background:
- Graft-versus-host disease (GVHD) is a common complication following allogeneic bone marrow transplantation.
- Cyclosporine (CsA) is an immunosuppressive drug frequently used to prevent GVHD.
- Nephrotic syndrome is a kidney disorder characterized by heavy protein loss in the urine.
Observation:
- A patient receiving a bone marrow transplant developed nephrotic syndrome.
- The patient had chronic graft-versus-host disease (GVHD).
- Nephrotic syndrome emerged after withdrawal of cyclosporine (CsA) treatment.
Findings:
- Renal biopsy confirmed the presence of membranous glomerulonephritis (MG).
- The findings suggest a potential autoimmune mechanism linking GVHD, membranous glomerulonephritis, and CsA withdrawal.
- Immunological features of GVHD in animal models may offer insights into this association.
Implications:
- This case highlights a potential renal complication of chronic GVHD and CsA therapy.
- Understanding the interplay between GVHD, immunosuppression, and autoimmune kidney disease is crucial.
- Further research may elucidate the specific immunological pathways involved.